Compound Evidence File
#EC-2026-0541
Bronchogen
Filed under Peptides. The bureau holds 119 laboratory returns for this compound from 50 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
50 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 9.9 | 10.0 | 8 Mar 2026 | 20 May 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 10.0 | 9.9 | 10.0 | 9 Dec 2025 | 16 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 6 Feb 2026 | 22 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 13 Apr 2026 | 15 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 9.9 | 10.0 | 8 Jan 2026 | 8 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 10.0 | 10.0 | 10.0 | 11 Dec 2025 | 7 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 10.0 | 10.0 | 10.0 | 9 Jan 2026 | 11 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 10.0 | 10.0 | 10.0 | 26 Mar 2026 | 4 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 10.0 | 10.0 | 10.0 | 5 Apr 2026 | 6 Jul 2026 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | X | 1 | 10.0 | 10.0 | 10.0 | 6 May 2025 | 6 May 2025 |
| Paradigm PeptideCASE #VI-2026-0759 | X | 1 | 10.0 | 10.0 | 10.0 | 7 May 2025 | 7 May 2025 |
| Pure Tested PeptidesCASE #VI-2026-0225 | X | 1 | 10.0 | 10.0 | 10.0 | 11 Jun 2025 | 11 Jun 2025 |
| HomopeptideCASE #VI-2026-0760 | A | 7 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 9.9 | 9.9 | 10.0 | 23 Feb 2026 | 8 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 9.9 | 9.9 | 9.9 | 1 Mar 2026 | 28 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 9.9 | 9.9 | 10.0 | 3 Jan 2026 | 27 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 9.9 | 9.9 | 10.0 | 23 Jun 2026 | 6 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 10.0 | 3 Jun 2026 | 19 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 10.0 | 8 May 2026 | 14 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 10.0 | 8 Apr 2026 | 14 Apr 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 10.0 | 21 Jul 2026 | 23 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 9.9 | 9.9 | 10.0 | 10 May 2026 | 15 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 25 Apr 2026 | 25 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 14 Apr 2026 | 11 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 10.0 | 12 Feb 2026 | 22 Jul 2026 |
| InjectifyCASE #VI-2026-0387 | X | 1 | 9.0 | 9.0 | 9.0 | 2 Jul 2025 | 2 Jul 2025 |
| Hunan Ruiwang Technology CenterCASE #VI-2026-0027 | X | 1 | 8.7 | 8.7 | 8.7 | 2 Jul 2025 | 2 Jul 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.5 | 6.0 | 10.0 | 24 May 2026 | 24 May 2026 |
| Pure RawzCASE #VI-2026-0767 | X | 1 | 8.3 | 8.3 | 8.3 | 14 Jan 2025 | 14 Jan 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 8.0 | 6.0 | 9.7 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 8.0 | 7.5 | 8.5 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 3 | 7.8 | 7.7 | 8.1 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 3 | 7.6 | 6.8 | 8.7 | 23 May 2026 | 23 May 2026 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 7.6 | 7.6 | 7.6 | 14 Jan 2025 | 14 Jan 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 7.6 | 7.6 | 7.6 | 8 Jul 2025 | 8 Jul 2025 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 7.4 | 7.4 | 7.4 | 11 Jun 2025 | 11 Jun 2025 |
| Mix PeptidesCASE #VI-2026-0699 | X | 1 | 7.2 | 7.2 | 7.2 | 24 Apr 2025 | 24 Apr 2025 |
| YimeiCASE #VI-2026-0081 | X | 4 | 7.0 | 5.9 | 8.4 | 7 May 2025 | 24 May 2026 |
| Xingruida XDRCASE #VI-2026-0898 | X | 3 | 6.8 | 6.3 | 7.7 | 16 Mar 2025 | 25 May 2026 |
| PeptiSlimCASE #VI-2026-0557 | X | 1 | 6.6 | 6.6 | 6.6 | 20 Jun 2025 | 20 Jun 2025 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 6.4 | 6.4 | 6.4 | 14 Jan 2025 | 14 Jan 2025 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 6.2 | 6.2 | 6.2 | 13 Feb 2025 | 13 Feb 2025 |
| Peptide WorldwideCASE #VI-2026-0217 | X | 1 | 5.6 | 5.6 | 5.6 | 13 Feb 2025 | 13 Feb 2025 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 5.2 | 5.2 | 5.2 | 13 Feb 2025 | 13 Feb 2025 |
| HealthTide BiotechCASE #VI-2026-0955 | X | 1 | 5.0 | 5.0 | 5.0 | 14 Jan 2025 | 14 Jan 2025 |
| Loti LabsCASE #VI-2026-0171 | X | 1 | 4.6 | 4.6 | 4.6 | 3 Jun 2025 | 3 Jun 2025 |
| Peptide GurusCASE #VI-2026-0854 | X | 4 | 2.7 | 2.0 | 3.4 | 21 May 2025 | 21 May 2026 |
| Wuhan Newtop BiotechCASE #VI-2026-0676 | X | 1 | 0.3 | 0.3 | 0.3 | 9 Jun 2025 | 9 Jun 2025 |
| Zhuoyue BiotechnologyCASE #VI-2026-0632 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Feb 2025 | 13 Feb 2025 |
Open any subject to view the batch-level evidence for Bronchogen alone.